Abstract
The aim of this chapter is to present the pathology of cardiac allograft rejection along with a brief historical background and summary of the clinical context and recent controversies. The intended audience is primarily pathologists, though it is also intended as a resource for heart failure/transplant investigators, clinicians, and surgeons seeking to better understand allograft biopsy interpretation. Different patterns of rejection are illustrated with emphasis on the most recent ISHLT working formulation classification schemes for cellular and antibody mediated rejection. An extensive discussion of immunopathology is also included. Nonrejection pathology encountered in transplant endomyocardial biopsies is addressed, including cardiac allograft vasculopathy. A brief section on the use of molecular pathology in rejection surveillance concludes the chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ackermann, D.M., Edwards, W.D.: Anatomic basis for tomographic analysis of the pediatric heart at autopsy. Perspect. Pediatr. Pathol. 12, 44–68 (1988)
Akhter, S.A., McGinty, J., Konys, J.J., Giesting, R.M., Merrill, W.H., Wagoner, L.E.: Recurrent primary cardiac malignant fibrous histiocytoma following orthotopic heart transplantation. J. Heart Lung Transplant. 23(12), 1447–1450 (2004)
Alkofer, B.J., Chiche, L., Khayat, A., Deshayes, J.P., Lepage, A., Saloux, E., Reznik, Y.: Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report of the first case and review of the literature. Transplant. Proc. 37(5), 2250–2252 (2005)
Baldwin 3rd, W.M., Samaniego-Picota, M., Kasper, E.K., Clark, A.M., Czader, M., Rohde, C., Zachary, A.A., Sanfilippo, F., Hruban, R.H.: Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes. Transplantation 68(6), 894–900 (1999)
Barnard, C.N.: Human cardiac transplantation. An evaluation of the first two operations performed at the Groote Schuur Hospital, Cape Town. Am. J. Cardiol. 22(4), 584–596 (1968)
Bayliss, J., Bailey, M., Leet, A., Stein, A.N., Thomson, N.M., McLean, C.A.: Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy. Transplantation 86(7), 991–997 (2008)
Billingham, M.E.: Diagnosis of cardiac rejection by endomyocardial biopsy. J. Heart Transplant. 1, 25–30 (1982)
Billingham, M.E.: The postsurgical heart. The pathology of cardiac transplantation. Am. J. Cardiovasc. Pathol. 1(3), 319–334 (1988)
Billingham, M.E.: Endomyocardial biopsy diagnosis of acute rejection in cardiac allografts. Prog. Cardiovasc. Dis. 33(1), 11–18 (1990)
Billingham, M.E.: Dilemma of variety of histopathologic grading systems for acute cardiac allograft rejection by endomyocardial biopsy. J. Heart Transplant. 9(3 Pt 2), 272–276 (1990)
Billingham, M.E.: Histopathology of graft coronary disease. J. Heart Lung Transplant. 11(3 Pt 2), S38–S44 (1992)
Billingham, M.E., Cary, N.R., Hammond, M.E., Kemnitz, J., Marboe, C., McCallister, H.A., Snovar, D.C., Winters, G.L., Zerbe, A.: A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J. Heart Transplant. 9(6), 587–593 (1990)
Billingham, M.E., Caves, P.K., Dong Jr., E., Shumway, N.E.: The diagnosis of canine orthotopic cardiac allograft rejection by transvenous endomyocardial biopsy. Transplant. Proc. 5(1), 741–743 (1973)
Bonnaud, E.N., Lewis, N.P., Masek, M.A., Billingham, M.E.: Reliability and usefulness of immunofluorescence in heart transplantation. J. Heart Lung Transplant. 14(1 Pt 1), 163–171 (1995)
Book, W.M., Kelley, L., Gravanis, M.B.: Fulminant mixed humoral and cellular rejection in a cardiac transplant recipient: a review of the histologic findings and literature. J. Heart Lung Transplant. 22(5), 604–607 (2003)
Botas, J., Pinto, F.J., Chenzbraun, A., Liang, D., Schroeder, J.S., Oesterle, S.N., Alderman, E.L., Popp, R.L., Yeung, A.C.: Influence of preexistent donor coronary artery disease on the progression of transplant vasculopathy. An intravascular ultrasound study. Circulation 92(5), 1126–1132 (1995)
Boucek, M.M., Aurora, P., Edwards, L.B., Taylor, D.O., Trulock, E.P., Christie, J., Dobbels, F., Rahmel, A.O., Keck, B.M., Hertz, M.I.: Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric heart transplantation report–2007. J. Heart Lung Transplant. 26(8), 796–807 (2007)
Bradshaw, S.H., Kennedy, L., Dexter, D.F., Veinot, J.P.: A practical method to rapidly dissolve metallic stents. Cardiovasc. Pathol. 18(3), 127–133 (2009)
Bray, R.A., Nickerson, P.W., Kerman, R.H., Gebel, H.M.: Evolution of HLA antibody detection: technology emulating biology. Immunol. Res. 29(1–3), 41–54 (2004)
Campos, S.V., Strabelli, T.M., Amato Neto, V., Silva, C.P., Bacal, F., Bocchi, E.A., Stolf, N.A.: Risk factors for Chagas’ disease reactivation after heart transplantation. J. Heart Lung Transplant. 27(6), 597–602 (2008)
Cardiac Transplantation: The Columbia University Medical Center/New York-Presbyterian Hospital Manual. Humana Press, Totowa, NJ. (2004)
Caves, P.K., Stinson, E.B., Billingham, M.E., Shumway, N.E.: Serial transvenous biopsy of the transplanted human heart. Improved management of acute rejection episodes. Lancet 1(7862), 821–826 (1974)
Cherry, R., Nielsen, H., Reed, E., Reemtsma, K., Suciu-Foca, N., Marboe, C.C.: Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulating anti-HLA antibodies. J. Heart Lung Transplant. 11(1 Pt 1), 24–29 (1992). discussion 30
Chu, K.E., Ho, E.K., de la Torre, L., Vasilescu, E.R., Marboe, C.C.: The relationship of nodular endocardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplantation. Cardiovasc. Pathol. 14(4), 219–224 (2005)
Colvin, R.B.: Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J. Am. Soc. Nephrol. 18(4), 1046–1056 (2007)
Cooper, D.K.: Clinical survey of heart transplantation between ABO blood group-incompatible recipients and donors. J. Heart Transplant. 9(4), 376–381 (1990)
Cooper, L.T., Baughman, K.L., Feldman, A.M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G.N., Narula, J., Starling, R.C., Towbin, J., Virmani, R.: The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116(19), 2216–2233 (2007)
Cooper Jr., L.T., Hare, J.M., Tazelaar, H.D., Edwards, W.D., Starling, R.C., Deng, M.C., Menon, S., Mullen, G.M., Jaski, B., Bailey, K.R., Cunningham, M.W., Dec, G.W.: Usefulness of immunosuppression for giant cell myocarditis. Am. J. Cardiol. 102(11), 1535–1539 (2008)
Costa, C., Touscoz, G.A., Bergallo, M., Terlizzi, M.E., Astegiano, S., Sidoti, F., Sinesi, F., Segoloni, G.P., Cavallo, R.: Non-organ-specific and anti-endothelial antibodies in relation to CMV infection and acute rejection in renal transplant recipients. Clin. Transplant. 19(4), e129–133(2009)
Costanzo, M.R., Haas, G.S.: Post-transplant care/medical complications. In: Young, J.B., Suki, W.N. (eds.) Primer on Transplantation, pp. 445–458. American Society of Transplant Physicians, Thorofare (1998)
Costanzo, M.R., Naftel, D.C., Pritzker, M.R., Heilman 3rd, J.K., Boehmer, J.P., Brozena, S.C., Dec, G.W., Ventura, H.O., Kirklin, J.K., Bourge, R.C., Miller, L.W.: Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J. Heart Lung Transplant. 17(8), 744–753 (1998)
Costanzo-Nordin, M.R., Heroux, A.L., Radvany, R., Koch, D., Robinson, J.A.: Role of humoral immunity in acute cardiac allograft dysfunction. J. Heart Lung Transplant. 12(2), S143–S146 (1993)
Curtil, A., Robin, J., Tronc, F., Ninet, J., Boissonnat, P., Champsaur, G.: Malignant neoplasms following cardiac transplantation. Eur. J. Cardiothorac. Surg. 12(1), 101–106 (1997)
De Santo, L.S., Amarelli, C., Romano, G., Della Corte, A., Maiello, C., Giannolo, B., Marra, C., De Feo, M., Scardone, M., Cotrufo, M.: High-risk heart grafts: effective preservation with Celsior solution. Heart Vessels 21(2), 89–94 (2006)
Del Rio, M.J.: Transplantation in complex congenital heart disease. Prog. Pediatr. Cardiol. 11, 107–113 (2000)
Deng, M.C., Eisen, H.J., Mehra, M.R., Billingham, M., Marboe, C.C., Berry, G., Kobashigawa, J., Johnson, F.L., Starling, R.C., Murali, S., Pauly, D.F., Baron, H., Wohlgemuth, J.G., Woodward, R.N., Klingler, T.M., Walther, D., Lal, P.G., Rosenberg, S., Hunt, S.: Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am. J. Transplant. 6(1), 150–160 (2006)
Derouin, F., Pelloux, H.: Prevention of toxoplasmosis in transplant patients. Clin. Microbiol. Infect. 14(12), 1089–1101 (2008)
Diaz, J.A., Booth, A.J., Lu, G., Wood, S.C., Pinsky, D.J., Bishop, D.K.: Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection. Am. J. Transplant. 9(8), 1773–1783 (2009)
Diez, M., Favaloro, L., Bertolotti, A., Burgos, J.M., Vigliano, C., Lastra, M.P., Levin, M.J., Arnedo, A., Nagel, C., Schijman, A.G., Favaloro, R.R.: Usefulness of PCR strategies for early diagnosis of Chagas’ disease reactivation and treatment follow-up in heart transplantation. Am. J. Transplant. 7(6), 1633–1640 (2007)
Dubrey, S.W., Burke, M.M., Khaghani, A., Hawkins, P.N., Yacoub, M.H., Banner, N.R.: Long term results of heart transplantation in patients with amyloid heart disease. Heart 85(2), 202–207 (2001)
Edwards, W.D.: Anatomic basis for tomographic analysis of the heart at autopsy. Cardiol. Clin. 2(4), 485–506 (1984)
Eisen, H.J., Kobashigawa, J., Keogh, A., Bourge, R., Renlund, D., Mentzer, R., Alderman, E., Valantine, H., Dureau, G., Mancini, D., Mamelok, R., Gordon, R., Wang, W., Mehra, M., Constanzo, M.R., Hummel, M., Johnson, J.: Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J. Heart Lung Transplant. 24(5), 517–525 (2005)
Estorch, M., Camprecios, M., Flotats, A., Mari, C., Berna, L., Catafau, A.M., Ballester, M., Narula, J., Carrio, I.: Sympathetic reinnervation of cardiac allografts evaluated by 123I-MIBG imaging. J. Nucl. Med. 40(6), 911–916 (1999)
Fan, X., Ang, A., Pollock-Barziv, S.M., Dipchand, A.I., Ruiz, P., Wilson, G., Platt, J.L., West, L.J.: Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat. Med. 10(11), 1227–1233 (2004)
Fearon, W.F., Potena, L., Hirohata, A., Sakurai, R., Yamasaki, M., Luikart, H., Lee, J., Vana, M.L., Cooke, J.P., Mocarski, E.S., Yeung, A.C., Valantine, H.A.: Changes in coronary arterial dimensions early after cardiac transplantation. Transplantation 83(6), 700–705 (2007)
Feucht, H.E., Felber, E., Gokel, M.J., Hillebrand, G., Nattermann, U., Brockmeyer, C., Held, E., Riethmuller, G., Land, W., Albert, E.: Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin. Exp. Immunol. 86(3), 464–470 (1991)
Forbes, R.D., Rowan, R.A., Billingham, M.E.: Endocardial infiltrates in human heart transplants: a serial biopsy analysis comparing four immunosuppression protocols. Hum. Pathol. 21(8), 850–855 (1990)
Funch, D.P., Walker, A.M., Schneider, G., Ziyadeh, N.J., Pescovitz, M.D.: Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients. Am. J. Transplant. 5(12), 2894–2900 (2005)
Gao, S.Z., Alderman, E.L., Schroeder, J.S., Silverman, J.F., Hunt, S.A.: Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J. Am. Coll. Cardiol. 12(2), 334–340 (1988)
Gao, S.Z., Chaparro, S.V., Perlroth, M., Montoya, J.G., Miller, J.L., DiMiceli, S., Hastie, T., Oyer, P.E., Schroeder, J.: Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30–year experience at Stanford University. J. Heart Lung Transplant. 22(5), 505–514 (2003)
Gareau, A., Hirsch, G.M., Lee, T.D., Nashan, B.: Contribution of B cells and antibody to cardiac allograft vasculopathy. Transplantation 88(4), 470–477 (2009)
Garlicki, M.: May preservation solution affect the incidence of graft vasculopathy in transplanted heart? Ann. Transplant. 8(1), 19–24 (2003)
Grauhan, O.: Criteria for the assessment of the donor heart. Transplant. Proc. 35(6), 2111–2112 (2003)
Hammond, E.H., Hansen, J.K., Spencer, L.S., Jensen, A., Riddell, D., Craven, C.M., Yowell, R.L.: Vascular rejection in cardiac transplantation: histologic, immunopathologic, and ultrastructural features. Cardiovasc. Pathol. 2(1), 21–34 (1993)
Hammond, E.H., Menlove, R.L., Yowell, R.L., Anderson, J.L.: Vascular HLA-DR expression correlates with pathologic changes suggestive of ischemia in idiopathic dilated cardiomyopathy. Clin. Immunol. Immunopathol. 68(2), 197–203 (1993)
Hammond, M.E.H., Renlund, D.G.: Cardiac allograft vascular (microvascular) rejection. Curr. Opin. Organ Transplant. 7(3), 233–239 (2002)
Hammond, M.E., Stehlik, J., Snow, G., Renlund, D.G., Seaman, J., Dabbas, B., Gilbert, E.M., Stringham, J.C., Long, J.W., Kfoury, A.G.: Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3, 170 biopsies. J. Heart Lung Transplant. 24(12), 2015–2021 (2005)
Hammond, E.H., Wittwer, C.T., Greenwood, J., Knape, W.A., Yowell, R.L., Menlove, R.L., Craven, C., Renlund, D.G., Bristow, M.R., DeWitt, C.W., et al.: Relationship of OKT3 sensitization and vascular rejection in cardiac transplant patients receiving OKT3 rejection prophylaxis. Transplantation 50(5), 776–782 (1990)
Hammond, E.H., Yowell, R.L.: Ultrastructural findings in cardiac transplant recipients. Ultrastruct. Pathol. 18(1–2), 213–220 (1994)
Hammond, E.A., Yowell, R.L., Greenwood, J., Hartung, L., Renlund, D., Wittwer, C.: Prevention of adverse clinical outcome by monitoring of cardiac transplant patients for murine monoclonal CD3 antibody (OKT3) sensitization. Transplantation 55(5), 1061–1063 (1993)
Hammond, E.H., Yowell, R.L., Nunoda, S., Menlove, R.L., Renlund, D.G., Bristow, M.R., Gay Jr., W.A., Jones, K.W., O’Connell, J.B.: Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J. Heart Transplant. 8(6), 430–443 (1989)
Harris, N.L., Swerdlow, S.H., Frizzera, G., Knowles, D.M., et al.: Post transplant lymphoproliferative disorders. In: Jaffe, E.S. (ed.) Pathology & Genetics of Tumors of Haematopoietic and Lymphoid Tissues, pp. 264–269. IARC, Lyon (2001)
Hertz, M.I., Aurora, P., Christie, J.D., Dobbels, F., Edwards, L.B., Kirk, R., Kucheryavaya, A.Y., Rahmel, A.O., Rowe, A.W., Taylor, D.O.: Registry of the International Society for Heart and Lung Transplantation: a quarter century of thoracic transplantation. J. Heart Lung Transplant. 27(9), 937–942 (2008)
Heublein, B., Haverich, A., Borst, H.G.: Long-term follow-up after o rthotopic heart transplantation. Thorac. Cardiovasc. Surg. 38(5), 285–290 (1990)
Higuchi, M.L., Benvenuti, L.A., Demarchi, L.M., Libby, P.: Histological evidence of concomitant intramyocardial and epicardial vasculitis in necropsied heart allografts: a possible relationship with graft coronary arteriosclerosis. Transplantation 67(12), 1569–1576 (1999)
Holt, D.B., Liapis, H., Mohanakumar, T., Phelan, D.R., Gandi, S.K., Huddleston, C.B., Canter, C.E.: Complement fragment C4d and C3d deposition in pediatric heart recipients with a positive crossmatch. J. Heart Lung Transplant. 27(10), 1073–1078 (2008)
Hsu, R.B., Fang, C.T., Chang, S.C., Chou, N.K., Ko, W.J., Wang, S.S., Chu, S.H.: Infectious complications after heart transplantation in Chinese recipients. Am. J. Transplant. 5(8), 2011–2016 (2005)
Huddleston, C.B., Rosenbloom, M., Goldstein, J.A., Pasque, M.K.: Biopsy-induced tricuspid regurgitation after cardiac transplantation. Ann. Thorac. Surg. 57(4), 832–836 (1994). discussion 836–837
Imakita, M., Billingham, M.E.: Endocardial infiltrates: the “Quilty” effect. J. Heart Lung Transplant. 7, 57 (1988)
Johnson, D.E., Gao, S.Z., Schroeder, J.S., DeCampli, W.M., Billingham, M.E.: The spectrum of coronary artery pathologic findings in human cardiac allografts. J. Heart Transplant. 8(5), 349–359 (1989)
Joshi, A., Masek, M.A., Brown Jr., B.W., Weiss, L.M., Billingham, M.E.: “Quilty” revisited: a 10-year perspective. Hum. Pathol. 26(5), 547–557 (1995)
Jurcevic, S., Ainsworth, M.E., Pomerance, A., Smith, J.D., Robinson, D.R., Dunn, M.J., Yacoub, M.H., Rose, M.L.: Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 71(7), 886–892 (2001)
Kaczmarek, I., Deutsch, M.A., Kauke, T., Beiras-Fernandez, A., Schmoeckel, M., Vicol, C., Sodian, R., Reichart, B., Spannagl, M., Ueberfuhr, P.: Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant. Exp. Clin. Transplant. 6(3), 229–235 (2008)
Kass, M., Allan, R., Haddad, H.: Diagnosis of graft coronary artery disease. Curr. Opin. Cardiol. 22(2), 139–145 (2007)
Kemnitz, J., Cohnert, T., Schafers, H.J., Helmke, M., Wahlers, T., Herrmann, G., Schmidt, R.M., Haverich, A.: A classification of cardiac allograft rejection. A modification of the classification by Billingham. Am. J. Surg. Pathol. 11(7), 503–515 (1987)
Kfoury, A.G., Renlund, D.G., Snow, G.L., Stehlik, J., Folsom, J.W., Fisher, P.W., Reid, B.B., Clayson, S.E., Gilbert, E.M., Everitt, M.D., Bader, F.M., Singhal, A.K., Hammond, M.E.: A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation. J. Heart Lung Transplant. 28(1), 51–57 (2009)
Kfoury, A.G., Stehlik, J., Renlund, D.G., Snow, G., Seaman, J.T., Gilbert, E.M., Stringham, J.S., Long, J.W., Hammond, M.E.: Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns. J. Heart Lung Transplant. 25(11), 1277–1282 (2006)
Klingenberg, R., Koch, A., Schnabel, P.A., Zimmermann, R., Sack, F.U., Haass, M., Dengler, T.J.: Allograft rejection of ISHLT grade >/=3A occurring late after heart transplantation–a distinct entity? J. Heart Lung Transplant. 22(9), 1005–1013 (2003)
Labarrere, C.A.: Relationship of fibrin deposition in microvasculature to outcomes in cardiac transplantation. Curr. Opin. Cardiol. 14(2), 133–139 (1999)
Lacy, M.Q., Dispenzieri, A., Hayman, S.R., Kumar, S., Kyle, R.A., Rajkumar, S.V., Edwards, B.S., Rodeheffer, R.J., Frantz, R.P., Kushwaha, S.S., Clavell, A.L., Dearani, J.A., Sundt, T.M., Daly, R.C., McGregor, C.G., Gastineau, D.A., Litzow, M.R., Gertz, M.A.: Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy. J. Heart Lung Transplant. 27(8), 823–829 (2008)
Latif, N., Rose, M.L., Yacoub, M.H., Dunn, M.J.: Association of pretransplantation antiheart antibodies with clinical course after heart transplantation. J. Heart Lung Transplant. 14(1 Pt 1), 119–126 (1995)
Leprince, P., Fretz, C., Dorent, R., Boudifa, A., Jourdan, J., Youssoub, J.J., Bors, V., Nataf, P., Pavie, A., Gandjbakhch, I.: Posttransplantation cytotoxic immunoglobulin G is associated with a high rate of acute allograft dysfunctions in heart transplant recipients. Am. Heart J. 138(3 Pt 1), 586–592 (1999)
Lloveras, J.J., Escourrou, G., Delisle, M.B., Fournial, G., Cerene, A., Bassanetti, I., Durand, D.: Evolution of untreated mild rejection in heart transplant recipients. J. Heart Lung Transplant. 11(4 Pt 1), 751–756 (1992)
Luk, A., Ahn, E., Lee, A., Ross, H.J., Butany, J.: Recurrent cardiac amyloidosis following previous heart transplantation. Cardiovasc. Pathol. (2009)
Mahle, W.T., Vincent, R.N., Berg, A.M., Kanter, K.R.: Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation. J. Heart Lung Transplant. 24(1), 63–66 (2005)
Marboe, C.C., Billingham, M., Eisen, H., Deng, M.C., Baron, H., Mehra, M., Hunt, S., Wohlgemuth, J., Mahmood, I., Prentice, J., Berry, G.: Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients. J. Heart Lung Transplant. 24(7 Suppl), S219–S226 (2005)
Marie, P.Y., Carteaux, J.P., Angioi, M., Marwan, N.S., Tzvetanov, K., Escanye, J.M., David, N., Mattei, S., Danchin, N., Karcher, G., Bertrand, A., Villemot, J.P.: Detection and prediction of acute heart transplant rejection: preliminary results on the clinical use of a“black blood” magnetic resonance imaging sequence. Transplant. Proc. 30(5), 1933–1935 (1998)
Martin, S., Brenchley, P.E., O’Donoghue, D.J., Dyer, P.A., Mallick, N.P., Johnson, R.W.: The identification of allo- and auto-lymphocytotoxic antibodies in serum, in the presence of rabbit antithymocyte globulin. Tissue Antigens 31(1), 26–32 (1988)
McAllister Jr., H.A.: Histologic grading of cardiac allograft rejection: a quantitative approach. J. Heart Transplant. 9(3 Pt 2), 277–282 (1990)
McGovern, P.C., Blumberg, E.A.: Differentiation between infection and rejection in the management of cardiac transplant patients. Curr. Infect. Dis. Rep. 3(4), 328–332 (2001)
Michaels, P.J., Espejo, M.L., Kobashigawa, J., Alejos, J.C., Burch, C., Takemoto, S., Reed, E.F., Fishbein, M.C.: Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J. Heart Lung Transplant. 22(1), 58–69 (2003)
Milano, A., Caforio, A.L., Livi, U., Bauce, B., Angelini, A., Casarotto, D., Thiene, G.: Evolution of focal moderate (International Society for Heart and Lung Transplantation grade 2) rejection of the cardiac allograft. J. Heart Lung Transplant. 15(5), 456–460 (1996)
Miller, L.W., Wesp, A., Jennison, S.H., Graham, M.A., Martin, T.W., McBride, L.R., Pennington, D.G., Peigh, P.: Vascular rejection in heart transplant recipients. J. Heart Lung Transplant. 12(2), S147–S152 (1993)
Moloney, E.D., Egan, J.J., Kelly, P., Wood, A.E., Cooper Jr., L.T.: Transplantation for myocarditis: a controversy revisited. J. Heart Lung Transplant. 24(8), 1103–1110 (2005)
Montoya, J.G., Giraldo, L.F., Efron, B., Stinson, E.B., Gamberg, P., Hunt, S., Giannetti, N., Miller, J., Remington, J.S.: Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin. Infect. Dis. 33(5), 629–640 (2001)
Morrell, C.N., Murata, K., Swaim, A.M., Mason, E., Martin, T.V., Thompson, L.E., Ballard, M., Fox-Talbot, K., Wasowska, B., Baldwin 3rd, W.M.: In vivo platelet-endothelial cell interactions in response to major histocompatibility complex alloantibody. Circ. Res. 102(7), 777–785 (2008)
Orens, J.B., Shearon, T.H., Freudenberger, R.S., Conte, J.V., Bhorade, S.M., Ardehali, A.: Thoracic organ transplantation in the United States, 1995–2004. Am. J. Transplant. 6(5 Pt 2), 1188–1197 (2006)
Pahl, E., Naftel, D.C., Canter, C.E., Frazier, E.A., Kirklin, J.K., Morrow, W.R.: Death after rejection with severe hemodynamic compromise in pediatric heart transplant recipients: a multi-institutional study. J. Heart Lung Transplant. 20(3), 279–287 (2001)
Palma, J.H., Guilhen, J.C., Gaia, D.F., Teles, A., Teles, C.A., Branco, J.N., Buffolo, E.: Post-transplant lymphoproliferative disease presenting as a mass in the left ventricle in a heart transplant recipient at long-term follow-up. J. Heart Lung Transplant. 28(2), 206–208 (2009)
Parfitt, J.R., Jayakumar, S., Driman, D.K.: Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes. Am. J. Surg. Pathol. 32(9), 1367–1372 (2008)
Pham, S.M., Kormos, R.L., Landreneau, R.J., Kawai, A., Gonzalez-Cancel, I., Hardesty, R.L., Hattler, B.G., Griffith, B.P.: Solid tumors after heart transplantation: lethality of lung cancer. Ann. Thorac. Surg. 60(6), 1623–1626 (1995)
Pierre-Louis, B., Kumar, A., Frishman, W.H.: Fabry disease: cardiac manifestations and therapeutic options. Cardiol. Rev. 17(1), 31–35 (2009)
Pilato, E., Dell’Amore, A., Botta, L., Arpesella, G.: Combined heart and liver transplantation for familial amyloidotic neuropathy. Eur. J. Cardiothorac. Surg. 32(1), 180–182 (2007)
Platt, J.L., Fischel, R.J., Matas, A.J., Reif, S.A., Bolman, R.M., Bach, F.H.: Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 52(2), 214–220 (1991)
Radovancevic, B., McGiffin, D.C., Kobashigawa, J.A., Cintron, G.B., Mullen, G.M., Pitts, D.E., O’Donnell, J., Thomas, C., Bourge, R.C., Naftel, D.C.: Retransplantation in 7,290 primary transplant patients: a 10-year multi-institutional study. J. Heart Lung Transplant. 22(8), 862–868 (2003)
Rahmani, M., Cruz, R.P., Granville, D.J., McManus, B.M.: Allograft vasculopathy versus atherosclerosis. Circ. Res. 99(8), 801–815 (2006)
Raichlin, E., Bae, J.H., Khalpey, Z., Edwards, B.S., Kremers, W.K., Clavell, A.L., Rodeheffer, R.J., Frantz, R.P., Rihal, C., Lerman, A., Kushwaha, S.S.: Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation 116(23), 2726–2733 (2007)
Raichlin, E., Edwards, B.S., Kremers, W.K., Clavell, A.L., Rodeheffer, R.J., Frantz, R.P., Pereira, N.L., Daly, R.C., McGregor, C.G., Lerman, A., Kushwaha, S.S.: Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation. J. Heart Lung Transplant. 28(4), 320–327 (2009)
Raichlin, E., Khalpey, Z., Kremers, W., Frantz, R.P., Rodeheffer, R.J., Clavell, A.L., Edwards, B.S., Kushwaha, S.S.: Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients. Transplantation 84(4), 467–474 (2007)
Reed, E.F., Demetris, A.J., Hammond, E., Itescu, S., Kobashigawa, J.A., Reinsmoen, N.L., Rodriguez, E.R., Rose, M., Stewart, S., Suciu-Foca, N., Zeevi, A., Fishbein, M.C.: Acute antibody-mediated rejection of cardiac transplants. J. Heart Lung Transplant. 25(2), 153–159 (2006)
Rippstein, P., Black, M.K., Boivin, M., Veinot, J.P., Ma, X., Chen, Y.X., Human, P., Zilla, P., O’Brien, E.R.: Comparison of processing and sectioning methodologies for arteries containing metallic stents. J. Histochem. Cytochem. 54(6), 673–681 (2006)
Rodriguez, E.R., Skojec, D.V., Tan, C.D., Zachary, A.A., Kasper, E.K., Conte, J.V., Baldwin 3rd, W.M.: Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am. J. Transplant. 5(11), 2778–2785 (2005)
Rose, A.U.: Pathology of acute rejection. In: Cooper, D.L. (ed.) Heart Transplant, pp. 157–176. MTP, Lancaster (1984)
Rose, A.G.: Understanding the pathogenesis and the pathology of hyperacute cardiac rejection. Cardiovasc. Pathol. 11(3), 171–176 (2002)
Rose, A.G., Cooper, D.K.: A histopathologic grading system of hyperacute (humoral, antibody-mediated) cardiac xenograft and allograft rejection. J. Heart Lung Transplant. 15(8), 804–817 (1996)
Rose, A.G., Cooper, D.K., Human, P.A., Reichenspurner, H., Reichart, B.: Histopathology of hyperacute rejection of the heart: experimental and clinical observations in allografts and xenografts. J. Heart Lung Transplant. 10(2), 223–234 (1991)
Santise, G., D’Ancona, G., Falletta, C., Pirone, F., Sciacca, S., Turrisi, M., Biondo, D., Pilato, M.: Donor pharmacological hemodynamic support is associated with primary graft failure in human heart transplantation. Interact. Cardiovasc. Thorac. Surg. 9(3), 476–479 (2009)
Sattar, H.A., Husain, A.N., Kim, A.Y., Krausz, T.: The presence of a CD21+ follicular dendritic cell network distinguishes invasive Quilty lesions from cardiac acute cellular rejection. Am. J. Surg. Pathol. 30(8), 1008–1013 (2006)
Seo, Y.L., Choi, C.S., Yoon, D.Y., Yun, E.J., Lee, Y.J., Park, S.J., Moon, J.H., Cho, S.J., Lee, S., Han, H., Kim, S.S., Lee, J.Y.: Benign breast diseases associated with cyclosporine therapy in renal transplant recipients. Transplant. Proc. 37(10), 4315–4319 (2005)
Shimizu, A., Colvin, R.B.: Pathological features of antibody-mediated rejection. Curr. Drug Targets Cardiovasc. Haematol. Disord. 5(3), 199–214 (2005)
Shimizu, A., Hisashi, Y., Kuwaki, K., Tseng, Y.L., Dor, F.J., Houser, S.L., Robson, S.C., Schuurman, H.J., Cooper, D.K., Sachs, D.H., Yamada, K., Colvin, R.B.: Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1, 3-galactosyltransferase gene-knockout pigs in baboons. Am. J. Pathol. 172(6), 1471–1481 (2008)
Smith, J.D., Hamour, I.M., Banner, N.R., Rose, M.L.: C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation. Am. J. Transplant. 7(12), 2809–2815 (2007)
Stahl, R.D., Karwande, S.V., Olsen, S.L., Taylor, D.O., Hawkins, J.A., Renlund, D.G.: Tricuspid valve dysfunction in the transplanted heart. Ann. Thorac. Surg. 59(2), 477–480 (1995)
Stehlik, J., Starling, R.C., Movsesian, M.A., Fang, J.C., Brown, R.N., Hess, M.L., Lewis, N.P., Kirklin, J.K.: Utility of long-term surveillance endomyocardial biopsy: a multi-institutional analysis. J. Heart Lung Transplant. 25(12), 1402–1409 (2006)
Stewart, T., Tsai, S.C., Grayson, H., Henderson, R., Opelz, G.: Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet 346(8978), 796–798 (1995)
Stewart, S., Winters, G.L., Fishbein, M.C., Tazelaar, H.D., Kobashigawa, J., Abrams, J., Andersen, C.B., Angelini, A., Berry, G.J., Burke, M.M., Demetris, A.J., Hammond, E., Itescu, S., Marboe, C.C., McManus, B., Reed, E.F., Reinsmoen, N.L., Rodriguez, E.R., Rose, A.G., Rose, M., Suciu-Focia, N., Zeevi, A., Billingham, M.E.: Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J. Heart Lung Transplant. 24(11), 1710–1720 (2005)
Tan, C.D., Baldwin 3rd, W.M., Rodriguez, E.R.: Update on cardiac transplantation pathology. Arch. Pathol. Lab. Med. 131(8), 1169–1191 (2007)
Tan, C.D., Sokos, G.G., Pidwell, D.J., Smedira, N.G., Gonzalez-Stawinski, G.V., Taylor, D.O., Starling, R.C., Rodriguez, E.R.: Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated rejection. Am. J. Transplant. 9(9), 2075–2084 (2009)
Taylor, D.O., Edwards, L.B., Boucek, M.M., Trulock, E.P., Aurora, P., Christie, J., Dobbels, F., Rahmel, A.O., Keck, B.M., Hertz, M.I.: Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report–2007. J. Heart Lung Transplant. 26(8), 769–781 (2007)
Taylor, D.O., Yowell, R.L., Kfoury, A.G., Hammond, E.H., Renlund, D.G.: Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection. J. Heart Lung Transplant. 19(6), 518–521 (2000)
Tazelaar, H.D.: Spectrum and diagnosis of myocardial rejection. Cardiol. Clin. 8(1), 119–139 (1990)
Tazelaar, H.D., Edwards, W.D.: Pathology of cardiac transplantation: recipient hearts (chronic heart failure) and donor hearts (acute and chronic rejection). Mayo Clin. Proc. 67(7), 685–696 (1992)
Uber, W.E., Self, S.E., Van Bakel, A.B., Pereira, N.L.: Acute antibody-mediated rejection following heart transplantation. Am. J. Transplant. 7(9), 2064–2074 (2007)
Uehara, S., Chase, C.M., Cornell, L.D., Madsen, J.C., Russell, P.S., Colvin, R.B.: Chronic cardiac transplant arteriopathy in mice: relationship of alloantibody, C4d deposition and neointimal fibrosis. Am. J. Transplant. 7(1), 57–65 (2007)
Valantine, H.A.: The role of viruses in cardiac allograft vasculopathy. Am. J. Transplant. 4(2), 169–177 (2004)
Veinot, J.P., Ascah, K., Davies, R.A., Smith, S.: Coronary artery-posterior interventricular vein fistula after endomyocardial biopsy in a heart transplant patient. Can. J. Cardiol. 18(2), 193–194 (2002)
Waller, B.F., Taliercio, C.P., Slack, J.D., Orr, C.M., Howard, J., Smith, M.L.: Tomographic views of normal and abnormal hearts: the anatomic basis for various cardiac imaging techniques. Part I. Clin. Cardiol. 13(11), 804–812 (1990)
Waller, B.F., Taliercio, C.P., Slack, J.D., Orr, C.M., Howard, J., Smith, M.L.: Tomographic views of normal and abnormal hearts: the anatomic basis for various cardiac imaging techniques. Part II. Clin. Cardiol. 13(12), 877–884 (1990)
Wang, S.S.: Treatment and prophylaxis of cardiac allograft vasculopathy. Transplant. Proc. 40(8), 2609–2610 (2008)
Warraich, R.S., Pomerance, A., Stanley, A., Banner, N.R., Dunn, M.J., Yacoub, M.H.: Cardiac myosin autoantibodies and acute rejection after heart transplantation in patients with dilated cardiomyopathy. Transplantation 69(8), 1609–1617 (2000)
West, L.J., Karamlou, T., Dipchand, A.I., Pollock-BarZiv, S.M., Coles, J.G., McCrindle, B.W.: Impact on outcomes after listing and transplantation, of a strategy to accept ABO blood group-incompatible donor hearts for neonates and infants. J. Thorac. Cardiovasc. Surg. 131(2), 455–461 (2006)
West, L.J., Pollock-Barziv, S.M., Lee, K.J., Dipchand, A.I., Coles, J.G., Ruiz, P.: Graft accommodation in infant recipients of ABO-incompatible heart transplants: donor ABH antigen expression in graft biopsies. J. Heart Lung Transplant. 20(2), 222 (2001)
Williams, J.M., Holzknecht, Z.E., Plummer, T.B., Lin, S.S., Brunn, G.J., Platt, J.L.: Acute vascular rejection and accommodation: divergent outcomes of the humoral response to organ transplantation. Transplantation 78(10), 1471–1478 (2004)
Winters, G.L., Loh, E., Schoen, F.J.: Natural history of focal moderate cardiac allograft rejection. Is treatment warranted? Circulation 91(7), 1975–1980 (1995)
Winters, G.L., McManus, B.M.: Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. Rapamycin Cardiac Rejection Treatment Trial Pathologists. J. Heart Lung Transplant. 15(7), 728–735 (1996)
Wu, Y.W., Yen, R.F., Lee, C.M., Ho, Y.L., Wang, S.S., Hsu, R.B., Chou, N.K., Huang, P.J.: Usefulness of progressive inhomogeneity of myocardial perfusion and chronotropic incompetence in detecting cardiac allograft vasculopathy: evaluation with dobutamine thallium-201 myocardial SPECT. Cardiology 104(3), 156–161 (2005)
Yager, J.E., Hernandez, A.F., Steenbergen, C., Persing, B., Russell, S.D., Milano, C., Felker, G.M.: Recurrence of cardiac sarcoidosis in a heart transplant recipient. J. Heart Lung Transplant. 24(11), 1988–1990 (2005)
Yeoh, T.K., Frist, W.H., Eastburn, T.E., Atkinson, J.: Clinical significance of mild rejection of the cardiac allograft. Circulation 86(5 Suppl), II267–II271 (1992)
Yeung, A.C., Davis, S.F., Hauptman, P.J., Kobashigawa, J.A., Miller, L.W., Valantine, H.A., Ventura, H.O., Wiedermann, J., Wilensky, R.: Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. Multicenter Intravascular Ultrasound Transplant Study Group. J. Heart Lung Transplant. 14(6 Pt 2), S215–S220 (1995)
Zerbe, T.R., Arena, V.: Diagnostic reliability of endomyocardial biopsy for assessment of cardiac allograft rejection. Hum. Pathol. 19(11), 1307–1314 (1988)
Zhang, Y., Zhang, X.D., Ma, L.L., Guan, D.L.: Relationship between platelet activation and acute rejection after renal transplantation. Transplant. Proc. 41(5), 1547–1551 (2009)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendix 1 Gross Pathology Record for Cardiac Explants
Appendix 1 Gross Pathology Record for Cardiac Explants
Rights and permissions
Copyright information
© 2009 Springer Berlin Heidelberg
About this chapter
Cite this chapter
Miller, D.V., Krigman, H., Canter, C. (2009). Heart. In: Liapis, H., Wang, H. (eds) Pathology of Solid Organ Transplantation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79343-4_9
Download citation
DOI: https://doi.org/10.1007/978-3-540-79343-4_9
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-79342-7
Online ISBN: 978-3-540-79343-4
eBook Packages: MedicineMedicine (R0)